[
  {
    "ts": null,
    "headline": "Charles River Laboratories International Inc. stock outperforms competitors on strong trading day",
    "summary": "Charles River Laboratories International Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=c3362560d2c59d8c5add978ebc95c4615f96a5f009715d0ea17e26807dcd125a",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741195260,
      "headline": "Charles River Laboratories International Inc. stock outperforms competitors on strong trading day",
      "id": 133035225,
      "image": "",
      "related": "CRL",
      "source": "MarketWatch",
      "summary": "Charles River Laboratories International Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=c3362560d2c59d8c5add978ebc95c4615f96a5f009715d0ea17e26807dcd125a"
    }
  },
  {
    "ts": null,
    "headline": "FairJourney Biologics Acquires Charles River Laboratories South San Francisco Facility",
    "summary": "Porto, Portugal, San Francisco - FairJourney Biologics S.A., leaders in the discovery and optimization of antibodies, today announced that it had completed the acquisition of the South San Francisco...",
    "url": "https://finnhub.io/api/news?id=f1cd089b29e2ead5d67285f9aef9c156995b9693d9264d1099d3344ac2c885db",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741174360,
      "headline": "FairJourney Biologics Acquires Charles River Laboratories South San Francisco Facility",
      "id": 133015796,
      "image": "",
      "related": "CRL",
      "source": "Finnhub",
      "summary": "Porto, Portugal, San Francisco - FairJourney Biologics S.A., leaders in the discovery and optimization of antibodies, today announced that it had completed the acquisition of the South San Francisco...",
      "url": "https://finnhub.io/api/news?id=f1cd089b29e2ead5d67285f9aef9c156995b9693d9264d1099d3344ac2c885db"
    }
  },
  {
    "ts": null,
    "headline": "Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4",
    "summary": "Looking back on drug development inputs & services stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Charles River Laboratories (NYSE:CRL) and its peers.",
    "url": "https://finnhub.io/api/news?id=3b56a4eccc1889b567aed12bfb31a6e5e5fe5ccdc35dee5cc42114e42da17591",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741165316,
      "headline": "Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4",
      "id": 133193995,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "Looking back on drug development inputs & services stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Charles River Laboratories (NYSE:CRL) and its peers.",
      "url": "https://finnhub.io/api/news?id=3b56a4eccc1889b567aed12bfb31a6e5e5fe5ccdc35dee5cc42114e42da17591"
    }
  }
]